Gu Sheng Tang TCM Pte Ltd

Background

Founded in 2010 and headquartered in Guangzhou, China, Gushengtang TCM Chain Management Group (“Gushengtang”) is a leading provider of Traditional Chinese Medicine (TCM) services, integrating diagnosis and treatment, drug R&D, and talent acquisition. Listed on the Hong Kong Stock Exchange (stock code: 02273.HK) on December 10, 2021, Gushengtang became the first publicly traded TCM medical chain service organization. In

April 2024, Gushengtang expanded overseas by acquiring Singapore Bao Zhong Tang 宝中堂, a premium TCM centre established in 2007, co-founded by Shanghai Shenkang Hospital and SingHealth in Singapore General Hospital, Southeast Asia’s most established Western medical institution, and, subsequently relocated in 2013 to Novena Specialist Centre, a preferred referral hub for exceptional outpatient TCM services.

On 27 December 2024, Bao Zhong Tang was officially renamed Gushengtang, becoming a leading Chinese medicine center in Singapore, offering premier TCM diagnosis and treatment services while promoting the development of integrated Chinese and Western medicine. Gushengtang envisions modernising and professionalising TCM in the region, with a focus on sustainable development through scientific research, knowledge-sharing, and fostering a deeper understanding of TCM to promote national health and growth.

Guided by its motto, “Conscientious Medicine, Assured Medicine” Gushengtang utilises TCM pulse diagnosis alongside external therapies such as acupuncture, manipulative therapy, cupping, and scraping. It upholds strict quality standards in Chinese medicine, tailoring treatment plans and optimising services to suit each patient’s unique health profile.